武汉永璨生物科技有限公司
+86-17702719238 sales@sun-shinechem.com

VAS3947

编号: 20302
Cas号: 869853-70-3
纯度: ≧98.0%

VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentrations, interfering neither with ROS detection nor with XOD or eNOS activities.

仅供研究使用。 我们不向患者出售。

化学信息

名称VAS3947
Iupac 化学名称3-Benzyl-7-(2-oxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine
同义词VA-S3947; VA S3947; VAS3947
英文同义词VA-S3947; VA S3947; VAS3947
分子式C14H10N6OS
分子量310.33
SmileC12=NC=NC(SC3=NC=CO3)=C1N=NN2CC4=CC=CC=C4
InChiKeyJVZDLDFNSCFLPM-UHFFFAOYSA-N
InChiInChI=1S/C14H10N6OS/c1-2-4-10(5-3-1)8-20-12-11(18-19-20)13(17-9-16-12)22-14-15-6-7-21-14/h1-7,9H,8H2
Cas号869853-70-3
相关CAS号869853-70-3

订购信息

包装价格库存纯度备货期
大货询价询价询价
Request Bulk Quote Download MSDS 电话 : +86-177 0271 9238   Email : sales@sun-shinechem.com
外观性状类白色至淡黄色固体
纯度≧98.0%
存储0-4℃,可保存几天到几周;-20℃,可保存 几个月。
可溶性溶于DMSO
处理方式Refer to MSDS
运输条件可以在室温下进行运输。
海关编码2934200090
Coming soon.
Targets
Mechanism
Cell study
Animal study
Clinical study

1: Hecht N, Terveer N, Schollmayer C, Holzgrabe U, Meinel L. Opening NADPH oxidase inhibitors for in vivo translation. Eur J Pharm Biopharm. 2017 Jun;115:206-217. doi: 10.1016/j.ejpb.2017.03.001. Epub 2017 Mar 8. PubMed PMID: 28284727.

2: Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31. doi: 10.1016/j.vph.2012.02.012. Epub 2012 Mar 3. Review. PubMed PMID: 22405985; PubMed Central PMCID: PMC3378316.

3: Wind S, Beuerlein K, Eucker T, Müller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol. 2010 Oct;161(4):885-98. doi: 10.1111/j.1476-5381.2010.00920.x. PubMed PMID: 20860666; PubMed Central PMCID: PMC2970907.


化学结构

20302 - VAS3947 | CAS 869853-70-3

快速订购

Change